These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29883107)

  • 1. Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach.
    Hoffer L; Voitovich YV; Raux B; Carrasco K; Muller C; Fedorov AY; Derviaux C; Amouric A; Betzi S; Horvath D; Varnek A; Collette Y; Combes S; Roche P; Morelli X
    J Med Chem; 2018 Jul; 61(13):5719-5732. PubMed ID: 29883107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.
    Franzini RM; Neri D; Scheuermann J
    Acc Chem Res; 2014 Apr; 47(4):1247-55. PubMed ID: 24673190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry-driven Hit-to-lead Optimization Guided by Structure-based Approaches.
    Hoffer L; Muller C; Roche P; Morelli X
    Mol Inform; 2018 Sep; 37(9-10):e1800059. PubMed ID: 30051601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CovaDOTS: In Silico Chemistry-Driven Tool to Design Covalent Inhibitors Using a Linking Strategy.
    Hoffer L; Saez-Ayala M; Horvath D; Varnek A; Morelli X; Roche P
    J Chem Inf Model; 2019 Apr; 59(4):1472-1485. PubMed ID: 30908019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
    Ferreira LG; Andricopulo AD
    Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From fragment screening to potent binders: strategies for fragment-to-lead evolution.
    Eitner K; Koch U
    Mini Rev Med Chem; 2009 Jul; 9(8):956-61. PubMed ID: 19601891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
    Kim J; Kim H; Park SB
    J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ChemoDOTS: a web server to design chemistry-driven focused libraries.
    Hoffer L; Charifi-Hoareau G; Barelier S; Betzi S; Miller T; Morelli X; Roche P
    Nucleic Acids Res; 2024 Jul; 52(W1):W461-W468. PubMed ID: 38686808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using DNA-encoded libraries of fragments for hit discovery of challenging therapeutic targets.
    Zhao G; Zhu M; Li Y; Zhang G; Li Y
    Expert Opin Drug Discov; 2024 Jun; 19(6):725-740. PubMed ID: 38753553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.
    Beresini MH; Liu Y; Dawes TD; Clark KR; Orren L; Schmidt S; Turincio R; Jones SW; Rodriguez RA; Thana P; Hascall D; Gross DP; Skelton NJ
    J Biomol Screen; 2014 Jun; 19(5):758-70. PubMed ID: 24518067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically.
    Hu Q; Peng Z; Kostrowicki J; Kuki A
    Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment based drug design: from experimental to computational approaches.
    Kumar A; Voet A; Zhang KY
    Curr Med Chem; 2012; 19(30):5128-47. PubMed ID: 22934764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity & tractability revisited in collaborative small molecule phenotypic screening library design.
    Lahue BR; Glick M; Tudor M; Johnson SA; Diratsouian J; Wildey MJ; Burton M; Mazzola R; Wassermann AM
    Bioorg Med Chem; 2020 Jan; 28(1):115192. PubMed ID: 31837897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of protein binding pocket properties with hits' chemistries used in generation of ultra-large virtual libraries.
    Song RX; Nicklaus MC; Tarasova NI
    J Comput Aided Mol Des; 2024 May; 38(1):22. PubMed ID: 38753096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where Do Recent Small Molecule Clinical Development Candidates Come From?
    Brown DG; Boström J
    J Med Chem; 2018 Nov; 61(21):9442-9468. PubMed ID: 29920198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual Screening of a Chemically Diverse "Superscaffold" Library Enables Ligand Discovery for a Key GPCR Target.
    Grotsch K; Sadybekov AV; Hiller S; Zaidi S; Eremin D; Le A; Liu Y; Smith EC; Illiopoulis-Tsoutsouvas C; Thomas J; Aggarwal S; Pickett JE; Reyes C; Picazo E; Roth BL; Makriyannis A; Katritch V; Fokin VV
    ACS Chem Biol; 2024 Apr; 19(4):866-874. PubMed ID: 38598723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
    Zhao H; Gartenmann L; Dong J; Spiliotopoulos D; Caflisch A
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2493-6. PubMed ID: 24767840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.